Bio Path is engaged in the business of financing and commercializing novel cancer therapeutics acquired from MD Anderson Cancer Center. Currently in Phase human trial.
Quote | Bio-Path Holdings Inc. (NASDAQ:BPTH)
Last: | $4.29 |
---|---|
Change Percent: | -1.19% |
Open: | $4.25 |
Close: | $4.29 |
High: | $4.5699 |
Low: | $3.8 |
Volume: | 2,128,246 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Bio-Path Holdings Inc. (NASDAQ:BPTH)
HOUSTON, April 19, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (the “Company” or “Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid ...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
Message Board Posts | Bio-Path Holdings Inc. (NASDAQ:BPTH)
Subject | By | Source | When |
---|---|---|---|
znewcar1: ML1.27 YH2.28 back under Feb? $BPTH | znewcar1 | investorshangout | 01/27/2023 6:37:54 PM |
znewcar1: ML3.55 LOD3.57 Don't think $3 will hold | znewcar1 | investorshangout | 09/16/2022 7:05:58 PM |
whytestocks: $BPTH News Article - Bio-Path Holdings to Announce Second Quarter 2022 Financial Result | whytestocks | investorshangout | 08/09/2022 11:00:54 PM |
Anyway, pps has been climbing slowly & steadily | cfoofme | investorshub | 07/09/2022 6:57:47 PM |
Anyone here still holding BPTH? | cfoofme | investorshub | 07/08/2022 11:30:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Bio-Path Holdings Inc. Company Name:
BPTH Stock Symbol:
NASDAQ Market:
Bio-Path Holdings Inc. Website:
HOUSTON, April 19, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH) (the "Company" or "Bio-Path"), a biotechnology company levera...
HOUSTON, April 19, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (the “Company” or “Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid ...
Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year incr...